You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company will consolidate its manufacturing activities in Kvistgaard, Denmark with the aim of optimizing productivity and profitability. As part of this consolidation, the company will prepare the Kvistgaard facility for the future commercial production of its prostate cancer vaccine, PROSTVACAlready a subscriber Login You have read all your free…
Swedish biotechnology start-up Cartana has announced the appointment of Mårten Winge as CEO. A spin-out from the SciLifeLab, Cartana has launched a new spatial cell type mapping service and reagent kits for neuroscientists. This enables gene expression to be mapped in tissue samples for the firsAlready a subscriber Login You…
Anocca has announced the closing of a USD 47 million (SEK 400 million) Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials. The financing, led by advisor Danske Bank, Already a subscriber Login You…
The company has successfully completed a directed share issue, which will provide it with a gross proceed of approximately SEK 324 million. The board of directors of Immunovia has resolved on a directed share issue of 2,162,794 new shares at a subscription price of SEK 150 per share. The subscripAlready…
